|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
IMVT | Levine Mark S. | Chief Legal Officer | Apr 24 | Sale | 28.90 | 3,963 | 114,531 | 343,156 | Apr 26 05:18 PM |
IMVT | Levine Mark S. | Chief Legal Officer | Apr 17 | Sale | 29.06 | 9,827 | 285,554 | 347,119 | Apr 19 06:06 PM |
IMVT | Levine Mark S. | Chief Legal Officer | Feb 22 | Sale | 36.15 | 2,134 | 77,144 | 301,968 | Feb 23 04:18 PM |
IMVT | Levine Mark S. | Chief Legal Officer | Jan 26 | Sale | 37.92 | 3,027 | 114,778 | 304,102 | Jan 29 04:12 PM |
IMVT | Levine Mark S. | Chief Legal Officer | Nov 22 | Sale | 32.78 | 3,252 | 106,598 | 307,129 | Nov 24 02:41 PM |
IMVT | Levine Mark S. | Chief Legal Officer | Oct 25 | Sale | 34.66 | 4,107 | 142,349 | 310,381 | Oct 27 04:04 PM |
IMVT | Levine Mark S. | Chief Legal Officer | Aug 24 | Sale | 20.30 | 12,286 | 249,406 | 314,488 | Aug 25 05:05 PM |
IMVT | Levine Mark S. | Chief Legal Officer | Jul 26 | Sale | 21.63 | 3,917 | 84,725 | 326,774 | Jul 27 04:33 PM |
IMVT | Levine Mark S. | Chief Legal Officer | Apr 25 | Sale | 16.29 | 2,633 | 42,892 | 330,691 | Apr 26 04:08 PM |
IMVT | Levine Mark S. | Chief Legal Officer | Jan 26 | Sale | 18.51 | 10,156 | 187,988 | 245,660 | Jan 27 07:20 AM |
NERV | Levine Mark S. | SVP,General Counsel & Sec. | Jun 01 | Option Exercise | 5.19 | 17,500 | 90,825 | 17,500 | Jun 05 04:33 PM |
NERV | Levine Mark S. | SVP,General Counsel & Sec. | Jun 01 | Sale | 11.00 | 17,500 | 192,500 | 0 | Jun 05 04:33 PM |
NERV | Levine Mark S. | SVP,General Counsel & Sec. | Jan 04 | Option Exercise | 4.72 | 17,500 | 82,545 | 17,500 | Jan 06 04:28 PM |
NERV | Levine Mark S. | SVP,General Counsel & Sec. | Jan 04 | Sale | 12.00 | 17,500 | 210,000 | 0 | Jan 06 04:28 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite